Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells

Published:2017-10 Issue: Volume:263 Page:151-161
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Gammon Joshua M.,Gosselin Emily A.,Tostanoski Lisa H.,Chiu Yu-Chieh,Zeng Xiangbin,Zeng Qin,Jewell Christopher M.

Funder

Damon Runyon Foundation

Melanoma Research Alliance

NSF CAREER Award

Alex's Lemonade Stand

Alliance for Cancer Gene Therapy

Alex's Lemonade Stand Foundation

NSF

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance;Andorko;AAPS J.,2015

2. Rational design of small molecules as vaccine adjuvants;Wu;Sci. Transl. Med.,2014

3. Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells;Waickman;J. Immunol.,2012

4. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2;Delgoffe;Nat. Immunol.,2011

5. mTOR signaling in growth control and disease;Laplante;Cell,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Organic Materials for Targeting Immunotherapies to Lymph Nodes;Chemistry of Materials;2024-08-30

2. PI3K/AKT/mTOR signaling regulates BCP ceramic-induced osteogenesis;Journal of Materials Chemistry B;2024

3. A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma;Human Vaccines & Immunotherapeutics;2023-06-30

4. Dissecting regulatory T cell expansion using polymer microparticles presenting defined ratios of self-antigen and regulatory cues;Frontiers in Bioengineering and Biotechnology;2023-06-27

5. Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy;ACS Applied Bio Materials;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3